Discovery Holds Promise for 'Bubble Boy’ Patients

December 07, 2013

An international study led by Dana-Farber Cancer Institute and Boston Children's Hospital has shown that a new type of gene therapy may help boys with a fatal immune disorder commonly known as “bubble boy” disease, the Boston Business Journal reports. A new delivery method for the gene therapy is designed to prevent patients from developing leukemia, a side effect that emerged during a similar trial 10 years ago, and doused hopes for the treatment.

Read the full story. Read the news release.

Media Inquiries

Irene Sege
Senior Media Relations Specialist

Follow Us!

Stay updated on our latest news and developments by following us on Twitter.

Twitter Logo